Your browser doesn't support javascript.
loading
Targeting HNRNPM Inhibits Cancer Stemness and Enhances Antitumor Immunity in Wnt-activated Hepatocellular Carcinoma.
Zhu, Gui-Qi; Wang, Yi; Wang, Biao; Liu, Wei-Ren; Dong, Shuang-Shuang; Chen, Er-Bao; Cai, Jia-Liang; Wan, Jing-Lei; Du, Jun-Xian; Song, Li-Na; Chen, Shi-Ping; Yu, Lei; Zhou, Zheng-Jun; Wang, Zheng; Zhou, Jian; Shi, Ying-Hong; Fan, Jia; Dai, Zhi.
Afiliação
  • Zhu GQ; Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China; State Key Laboratory of Genetic Engineering, Fudan University, Shanghai, China; Department of Liver Surgery and Transplantation, Zhongshan Hospital, Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion o
  • Wang Y; Department of Radiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Medical Imaging, Shanghai, China.
  • Wang B; Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China; State Key Laboratory of Genetic Engineering, Fudan University, Shanghai, China.
  • Liu WR; Department of Liver Surgery and Transplantation, Zhongshan Hospital, Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Shanghai, China.
  • Dong SS; Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China; State Key Laboratory of Genetic Engineering, Fudan University, Shanghai, China.
  • Chen EB; Hepato-Pancreato-Biliary Surgery, Peking University Shenzhen Hospital, Shenzhen, Guangdong, China.
  • Cai JL; Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China; State Key Laboratory of Genetic Engineering, Fudan University, Shanghai, China.
  • Wan JL; Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China; State Key Laboratory of Genetic Engineering, Fudan University, Shanghai, China.
  • Du JX; Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Song LN; Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China; State Key Laboratory of Genetic Engineering, Fudan University, Shanghai, China.
  • Chen SP; Department of Liver Surgery and Transplantation, Zhongshan Hospital, Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Shanghai, China.
  • Yu L; Department of Liver Surgery and Transplantation, Zhongshan Hospital, Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Shanghai, China.
  • Zhou ZJ; Department of Liver Surgery and Transplantation, Zhongshan Hospital, Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Shanghai, China.
  • Wang Z; Department of Liver Surgery and Transplantation, Zhongshan Hospital, Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Shanghai, China.
  • Zhou J; Department of Liver Surgery and Transplantation, Zhongshan Hospital, Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Shanghai, China.
  • Shi YH; Department of Liver Surgery and Transplantation, Zhongshan Hospital, Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Shanghai, China. Electronic address: shi.yinghong@zs-hospital.sh.cn.
  • Fan J; Department of Liver Surgery and Transplantation, Zhongshan Hospital, Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Shanghai, China. Electronic address: fan.jia@zs-hospital.sh.cn.
  • Dai Z; Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China; State Key Laboratory of Genetic Engineering, Fudan University, Shanghai, China. Electronic address: dai.zhi@zs-hospital.sh.cn.
Cell Mol Gastroenterol Hepatol ; 13(5): 1413-1447, 2022.
Article em En | MEDLINE | ID: mdl-35158098
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Ribonucleoproteínas Nucleares Heterogêneas Grupo M / Neoplasias Hepáticas Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Ribonucleoproteínas Nucleares Heterogêneas Grupo M / Neoplasias Hepáticas Idioma: En Ano de publicação: 2022 Tipo de documento: Article